Multiple sclerosis.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with definite or possible multiple sclerosis and suffer from fatigue Patients suffering from fatigue of multiple sclerosis for more than 6 months and confirmed with FSS score more than 30 Age range between 18-50 Not consuming any other fatigue relieving drugs except amantadine in control group
Exclusion criteria
Exclusion criteria: Probable cases of multiple sclerosis Pregnancy- lactating Acute fracture or trauma Patients with other chronic disease Patients with coagulation disorders Tobacco products use Refuse to continue the treatment Death
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue with FSS more than 30, quality of life improvement with SF-36. Timepoint: before treatment, immediately after treatment, 2 months post treatment. Method of measurement: FSS, SF-36 questionnaires. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences